<VariationArchive VariationID="3106" VariationName="NM_005670.4(EPM2A):c.953dup (p.Gln319fs)" VariationType="Duplication" Accession="VCV000003106" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2015-01-23" MostRecentSubmission="2015-01-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="18145" VariationID="3106">
      <GeneList>
        <Gene Symbol="EPM2A" FullName="EPM2A glucan phosphatase, laforin" GeneID="7957" HGNC_ID="HGNC:3413" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145383353" stop="145736023" display_start="145383353" display_stop="145736023" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145946439" stop="146056990" display_start="145946439" display_stop="146056990" Strand="-" />
          </Location>
          <OMIM>607566</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005670.4(EPM2A):c.953dup (p.Gln319fs)</Name>
      <CanonicalSPDI>NC_000006.12:145627458:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>6q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="145627458" stop="145627459" display_start="145627458" display_stop="145627459" variantLength="1" positionVCF="145627458" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="145948594" stop="145948595" display_start="145948594" display_stop="145948595" variantLength="1" positionVCF="145948594" referenceAlleleVCF="G" alternateAlleleVCF="GA" />
      </Location>
      <ProteinChange>Q319fs</ProteinChange>
      <ProteinChange>Q181fs</ProteinChange>
      <ProteinChange>Q165fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.145948600dup" Assembly="GRCh37">
            <Expression>NC_000006.11:g.145948600dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.145627464dup" Assembly="GRCh38">
            <Expression>NC_000006.12:g.145627464dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012832.2" sequenceAccession="NG_012832" sequenceVersion="2" change="g.113397dup">
            <Expression>NG_012832.2:g.113397dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360057.2" sequenceAccession="NM_001360057" sequenceVersion="2" change="c.*36dup">
            <Expression>NM_001360057.2:c.*36dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001624" Type="3 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360064.2" sequenceAccession="NM_001360064" sequenceVersion="2" change="c.539dup">
            <Expression>NM_001360064.2:c.539dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001346993.1" sequenceAccession="NP_001346993" sequenceVersion="1" change="p.Gln181fs">
            <Expression>NP_001346993.1:p.Gln181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001360071.2" sequenceAccession="NM_001360071" sequenceVersion="2" change="c.539dup">
            <Expression>NM_001360071.2:c.539dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001347000.1" sequenceAccession="NP_001347000" sequenceVersion="1" change="p.Gln181fs">
            <Expression>NP_001347000.1:p.Gln181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368129.2" sequenceAccession="NM_001368129" sequenceVersion="2" change="c.491dup">
            <Expression>NM_001368129.2:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355058.1" sequenceAccession="NP_001355058" sequenceVersion="1" change="p.Gln165fs">
            <Expression>NP_001355058.1:p.Gln165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368131.1" sequenceAccession="NM_001368131" sequenceVersion="1" change="c.539dup">
            <Expression>NM_001368131.1:c.539dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355060.1" sequenceAccession="NP_001355060" sequenceVersion="1" change="p.Gln181fs">
            <Expression>NP_001355060.1:p.Gln181fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001368132.1" sequenceAccession="NM_001368132" sequenceVersion="1" change="c.491dup">
            <Expression>NM_001368132.1:c.491dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001355061.1" sequenceAccession="NP_001355061" sequenceVersion="1" change="p.Gln165fs">
            <Expression>NP_001355061.1:p.Gln165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005670.4" sequenceAccession="NM_005670" sequenceVersion="4" change="c.953dup" MANESelect="true">
            <Expression>NM_005670.4:c.953dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005661.1" sequenceAccession="NP_005661" sequenceVersion="1" change="p.Gln319fs">
            <Expression>NP_005661.1:p.Gln319fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_153398.2" sequenceAccession="NR_153398" sequenceVersion="2" change="n.526dup">
            <Expression>NR_153398.2:n.526dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001018041.2" sequenceAccession="NM_001018041" sequenceVersion="2" change="c.924+24dup">
            <Expression>NM_001018041.2:c.924+24dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA252548" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607566.0009" DB="OMIM" />
        <XRef Type="rs" ID="587776554" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005670.4(EPM2A):c.953dup (p.Gln319fs) AND Myoclonic epilepsy of Lafora 1" Accession="RCV004576875" Version="1">
        <ClassifiedConditionList TraitSetID="96298">
          <ClassifiedCondition DB="MedGen" ID="C5848203">Myoclonic epilepsy of Lafora 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-01-23" MostRecentSubmission="2015-01-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">14722920</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16134145</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="96298" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="73290" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myoclonic epilepsy of Lafora 1</ElementValue>
                <XRef ID="MONDO:0958199" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LAFORA DISEASE 1</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPSY, PROGRESSIVE MYOCLONIC, 2A</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607566.0001" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MELF1</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EPM2A</ElementValue>
                <XRef Type="MIM" ID="254780" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301563</ID>
                <ID Source="BookShelf">NBK1389</ID>
              </Citation>
              <XRef ID="C5848203" DB="MedGen" />
              <XRef ID="MONDO:0958199" DB="MONDO" />
              <XRef Type="MIM" ID="254780" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23410" SubmissionDate="2015-01-20" DateLastUpdated="2015-01-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607566.0009_EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" title="EPM2A, 1-BP INS, 953T_EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" />
        <ClinVarAccession Accession="SCV000023410" DateUpdated="2015-01-23" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Ianzano et al. (2004) described the first case of Lafora disease (EPM2A; 254780) in which the mutation was specific to the cytoplasmic laforin isoform (isoform A). They identified a 1-bp insertion in the EPM2A gene, 950insT, which resulted in a frameshift after codon 319 (Q319fs). The patient developed normally with average school performance and an uneventful childhood. At age 14 years, she exhibited personality changes, became more anxious, and developed severe learning difficulties. At age 15 years, she had several generalized tonic-clonic seizures, and myoclonus appeared. EEG background was slow, with frequent paroxysmal generalized irregular spike-wave discharges. At age 22 years, she was bedridden, with continuous myoclonia, frequent generalized seizures, and dementia. She died at age 24 years. Muscle biopsy showed polyglucosan accumulations, and an axillary skin biopsy showed pathognomonic periodic acid-Schiff-positive inclusions (Lafora bodies) in myoepithelial cells of apocrine glands.</Attribute>
              <Citation>
                <ID Source="PubMed">14722920</ID>
              </Citation>
              <XRef DB="OMIM" ID="254780" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ianzano et al. (2005) stated that this insertion occurs at nucleotide 953 (953_954insT) in exon 4 of the laforin gene.</Attribute>
              <Citation>
                <ID Source="PubMed">16134145</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPM2A" />
          </GeneList>
          <Name>EPM2A, 1-BP INS, 953T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 953T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607566.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPILEPSY, PROGRESSIVE MYOCLONIC, 2A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23410" TraitType="Disease" MappingType="Name" MappingValue="EPILEPSY, PROGRESSIVE MYOCLONIC, 2A" MappingRef="Preferred">
        <MedGen CUI="C5848203" Name="Myoclonic epilepsy of Lafora 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

